Anxiety, Depression Common With Inflammatory Bowel Disease
WEDNESDAY, March 31, 2021 -- There is a high prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease (IBD), according to a review published online March 12 in The Lancet Gastroenterology & Hepatology.
Brigida Barberio, M.D., from the University of Padova in Italy, and colleagues conducted a systematic literature review and meta-analysis of data from studies of ≥100 adult patients with IBD that reported on the prevalence of symptoms of anxiety or depression.
Based on 77 eligible studies (30,118 patients), the researchers found that overall, the pooled prevalence of anxiety symptoms was 32.1 percent in 58 studies; the pooled prevalence of depression symptoms was 25.2 percent in 75 studies. Among studies that reported prevalence of anxiety or depression in patients with Crohn disease and ulcerative colitis, patients with Crohn disease had higher odds of anxiety symptoms (odds ratio, 1.2; 95 percent confidence interval, 1.1 to 1.4) and depression symptoms (odds ratio, 1.2; 95 percent confidence interval, 1.1 to 1.4) compared with patients with ulcerative colitis. Women were more likely than men with IBD to have symptoms of anxiety (pooled prevalence: 33.8 percent for women versus 22.8 percent for men; odds ratio, 1.7; 95 percent confidence interval, 1.2 to 2.3). Women were also more likely than men to have symptoms of depression (pooled prevalence: 21.2 percent for women versus 16.2 percent for men; odds ratio, 1.3; 95 percent confidence interval, 1.0 to 1.8).
"Encouraging gastroenterologists to screen for and treat these disorders might improve outcomes for patients with IBD," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
MONDAY, April 19, 2021 -- Adults with inflammatory bowel disease (IBD) have a higher prevalence of migraine or severe headache, according to a study published online March 23 in...
FRIDAY, April 16, 2021 -- People with a severe mental illness (SMI) are more likely to die following a heart attack than those without a psychiatric diagnosis, according to a...
THURSDAY, April 15, 2021 -- For patients with major depressive disorder, the change in scores for depression at six weeks does not differ significantly with psilocybin or...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.